House of Lords Business
Show full summary

Lord Sharkey to ask Her Majesty's Government what steps they have taken to ensure UK–EU clinical trials can continue after the end of the transition period, and once the EU?Clinical Trial Regulation?(Regulation (EU) No 536/2014) comes into effect.  HL4366

Question HL4366: tabled on 12 May 2020 and due for answer by 27 May 2020

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Sharkey to ask Her Majesty's Government what steps they have taken to ensure UK–EU clinical trials can continue after the end of the transition period, and once the EU?Clinical Trial Regulation?(Regulation (EU) No 536/2014) comes into effect.  HL4366
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Sharkey
Liberal Democrat
Life peer